Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure

Cd8+ t cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction

In-hospital mortality is associated with inflammatory response in nafld patients admitted for covid-19

Gastrointestinal motility disorders and their clinical implications in cirrhosis

Thrombin and factor xa link the coagulation system with liver fibrosis

Prediction of decompensation events in nash cirrhosis patients

A review of liver fibrosis and emerging therapies